Nutraceutical innovator DolCas Biotech, LLC, has successfully infused beneficial marine collagen tripeptides into a chocolate bar. Each square (about 8g) contains 1g of Morikol, an ultra-low-molecular ...

Nutraceutical innovator DolCas Biotech, LLC, has successfully infused beneficial marine collagen tripeptides into a chocolate ...

DolCas Biotech, a company known for its advancements in nutraceutical ingredients, has unveiled a novel approach to functional foods by incorporating marine collagen tripeptides into chocolate bars.

Livingstone College will host its fourth free biomanufacturing training program on campus from July 14-25, offering North Carolina residents a unique opportunity to gain hands-on experience in a ...

Discover the latest developments in the neuroplastogens field, including Elkedonia’s funding to address neuropsychiatric disorders.

Biotech is one of America’s most critical innovation sectors, but it is facing serious headwinds. Since COVID-19, the industry has been hammered by falling investor confidence, sluggish IPO markets, ...

Alto Neuroscience’s phase 2 depression trial has missed its primary efficacy endpoint, as patients on the drug candidate fared no better on a measure of alertness and mood than their peers on ...

Insmed's CEO keeps a newspaper story from 2014 in his office. The headline: “Insmed joins the biotech trash heap.” Now, he hopes the company can be a $100 billion biotech.

Cosmos Health (COSM) announced its entry into the U.S. market and the launch of U.S.-based manufacturing through a strategic agreement with DolCas Biotech LLC, a New Jersey-based developer and ...

DolCas Biotech, a developer and manufacturer of clinically studied nutraceutical ingredients, will produce Cosmos Health’s products at its U.S. facilities. The partnership aims to strengthen Cosmos ...